Article

Joint Prediction of Adjuvant Therapy Response and Time-to-Response for Cancer Patients Using the Personalized-DrugRank Method

2026-03-13

Abstract excerpt

<h4>Background</h4> The ideal of personalized medicine is to support the clinical decision process towards the right drug for the right patient at the right time, by using, among other diagnostic tools, molecular biomarkers that are specifically dependent on the patient status and on the therapeutic options. Several challenges must be overcome to realize this vision. Patients present a wide spectrum of genetic va...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e1e50514-548d-5002-86cb-e3cf7a9f2b0c
DOI: 10.64898/2026.03.12.26348235

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Joint Prediction of Adjuvant Therapy Response and Time-to-Response for Cancer Patients Using the Personalized-DrugRank MethodDOI 10.64898/2026.03.12.26348235Read

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeSemantic proximity Read

Personalizing chemotherapy drug selection using a novel transcriptomic chemogramSemantic proximity Read

FORESEE: a tool for the systematic comparison of translational drug response modeling pipelinesSemantic proximity Read

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to DiscoverySemantic proximity Read

Fast and robust method for drug response biomarker identification and sample stratificationSemantic proximity Read

Machine learning models to predict <i>in vivo</i> drug response via optimal dimensionality reduction of tumour molecular profilesSemantic proximity Read

DrDimont: Explainable drug response prediction from differential analysis of multi-omics networksSemantic proximity Read

Clinical interpretation of integrative molecular profiles to guide precision cancer medicineSemantic proximity Read

Dr.Paso: Drug response prediction and analysis system for oncology researchSemantic proximity Read

<b>PANOPLY:</b> Omics-guided drug prioritization method tailored to an individual patientSemantic proximity Read

Computational Advancements in Cancer Combination Therapy PredictionSemantic proximity Read

Machine learning model to predict oncologic outcomes for drugs in randomized clinical trials.Semantic proximity Read